Bausch Health
358 hedge funds and large institutions have $7.53B invested in Bausch Health in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 121 increasing their positions, 112 reducing their positions, and 40 closing their positions.
20% more call options, than puts
Call options by funds: $364M | Put options by funds: $303M
18% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 40
15% more funds holding in top 10
Funds holding in top 10: 20 → 23 (+3)
1.74% more ownership
Funds ownership: 69.81% → 71.54% (+1.7%)
1% more funds holding
Funds holding: 353 → 358 (+5)
8% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 112
5% less capital invested
Capital invested by funds: $7.91B → $7.53B (-$382M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$160M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$77.4M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.4M |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
+$47.1M |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$81.4M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$60M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$52.7M |
| 4 |
Morgan Stanley
New York
|
-$44.2M |
| 5 |
BlackRock
New York
|
-$39.4M |
BHC Hedge Fund Activity: Q2 2021 in Review
358 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2021, worth a combined $7.53B — down 4.8% from $7.91B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new BHC positions and 40 closed out — a net gain of 7 holders — while 121 added to existing stakes and 112 trimmed.
The largest buyer was Nomura Holdings, adding an estimated $160M. The largest seller was Bank of Montreal, cutting an estimated $81.4M.
- 358 institutional investors held Bausch Health (BHC) as of Q2 2021, up from 353 in Q1 2021.
- Funds reported $7.53B of Bausch Health stock for Q2 2021, down 4.8% quarter-over-quarter.
- 47 funds opened new Bausch Health positions in Q2 2021 and 40 closed out, a net change of +7 holders.
- The largest Bausch Health buyer in Q2 2021 was Nomura Holdings, an estimated $160M added.
- The largest Bausch Health seller in Q2 2021 was Bank of Montreal, an estimated $81.4M sold.
Based on aggregated 13F filings for Q2 2021.